8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina
|
|
- Lynne Parker
- 6 years ago
- Views:
Transcription
1 FIRST ANNOUNCEMENT 8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina The 8 th Conference of IAOC "Current Status and Future of Anti-Cancer Targeted Therapies" will be held in Buenos Aires, Argentina in October 17 th and 18 th, An outstanding faculty of speakers from the United States and Europe has committed in this meeting. The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development. The major emphasis will be on clinical aspects of cancer treatment in the 21 st century with discussion of significant scientific advances underlying the novel approaches still in preclinical development. This meeting is the primary opportunity for oncologists, hematologists and cancer related health workers to participate in a conference focusing on novel targeted therapies and other treatment advances which are changing the face of cancer care. CO- CHAIRS Alex Adjei, Rochester, USA Román Perez Soler, New York, USA Antoni Ribas, Los Angeles, USA ORGANIZING COMMITTEE Román Pérez Soler, New York, USA Andrea Blanco, Buenos Aires, Argentina SCIENTIFIC COMMITTEE Alex Adjei, M.D., Ph.D., Mayo Clinic, Rochester, USA Kenneth C. Anderson, M.D., Dana-Farber Cancer Institute Boston, Massachusetts, USA Carlos L. Arteaga, M.D., Harold C. Simmons Cancer Center, Texas, USA Roman Perez Soler, M.D., Albert Einstein College of Medicine, New York, USA Antoni Ribas, M.D., Ph.D., UCLA, Los Angeles, USA Josep Tabernero, M.D., Ph.D., Vall d'hebron University Hospital, Barcelona, Spain
2 FACULTY (PROVISIONARY) Alex A. Adjei, M.D., Ph.D. Consultant in Oncology Professor of Oncology Mayo Clinic Rochester, Minnesota, USA Kenneth C. Anderson, M.D. Kraft Family Harvard Medical School Dana-Farber Cancer Institute Boston, Massachusetts, USA Stephen M. Ansell, M.D., Ph.D. Chair Lymphoma Group Mayo Clinic Rochester, Minnesota, USA Carlos L. Arteaga, M.D. and Cancer Biology Director, UTSW Harold C. Simmons Cancer Center Associate Dean of Oncology Lisa K. Simmons Distinguished Chair in Comprehensive Oncology Dallas, Texas, USA Carlos H. Barrios, M.D. Hospital do Cancer Mãe de Deus Porto Alegre RS, Brazil Joaquim Bellmunt, M.D., Ph.D. Associate Professor, Medicine, Harvard Medical School Bladder Cancer Center Dana-Farber Cancer Institute Boston, Massachusetts, USA Jorge Cortés, M.D. Chief, CML & AML Sections Deputy Chair, Department of Leukemia M.D. Anderson Cancer Center Houston, Texas, USA 2
3 Charles Drake, M.D., Ph.D. * Co-Director, Cancer Immunotherapy Programs Director of genitourinary oncology Herbert Irving Comprehensive Cancer Center Columbia University Medical Center NY, New York, USA Román Pérez-Soler, M.D. Chairman, Department of Oncology Montefiore Medical Center and Molecular Pharmacology Deputy Cancer Center Director Albert Einstein College of Medicine Bronx,, New York, USA Gabriel A. Rabinovich, Ph.D. * Head of the Laboratoy of Immunopathology Instituto de Biología y Medicina Experimental (IBYME) Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Member of the USA National Academy of Sciences Buenos Aires, Argentina Antoni Ribas, M.D., Ph.D. and Surgery Professor of Molecular and Medical Pharmacology Director Tumor Immunology Program, Jonsson Comprehensive Cancer Center (JCCC) David Geffen School of Medicine, UCLA Chair, Melanoma Committee at SWOG Los Angeles, California, USA Josep Tabernero, M.D., Ph.D., Chairman Medical Oncology Department Vall d'hebron University Hospital Barcelona, Spain *TBC (to be confirmed) 3
4 PRELIMINARY PROGRAM NEW ANTICANCER THERAPIES Promising Novel Agents in Early Clinical Trials: Alex A. Adjei, Rochester, USA Novel Combination Approaches for Cancer Immunotherapy: TBA Immune Checkpoint Inhibitors for Melanoma: Antoni Ribas, California, USA Emerging Checkpoints in Immune and Vascular Signaling Programs in Cancer: Gabriel Rabinovich, Buenos Aires, Argentina (*TBC) Cancer Biomarkers: Antoni Ribas, California, USA The Evolution of Cancer Immunotherapy: Ignacio Melero, Pamplona, Spain (*TBC) BREAST CANCER New Drugs and treatments in Breast Cancer: Carlos L. Arteaga, Texas, USA Challenges in the Genomic Selection of Patients: Carlos Barrios, Porto Alegre, Brazil GU CANCER Novel Therapies in Prostate and Renal Cancer: Charles Drake, Columbia, USA (*TBC) The Evolution of Targeted Therapy and Checkpoint Inhibitors in Bladder Cancer: Joaquim Bellmunt, Barcelona, Spain GI CANCER Novel Therapies in Gastric Cancer: Josep Tabernero, Barcelona, Spain 4
5 New Treatment for Colorectal Cancer: Josep Tabernero, Barcelona, Spain LUNG CANCER What s new in the Management of SCLC: Alex A. Adjei, Rochester, USA Current Management of NSCLC: Román Pérez Soler, New York, USA Combination Immunotherapy for Lung Cancer: TBA HEMATOLOGICAL MALIGNANCIES New Developments in Lymphoma: Stephen Ansell, Rochester, USA Multiple Myeloma: Kenneth C. Anderson, Boston, USA Novel Drug Development in Leukemia: Jorge Cortés, Houston, USA CONFERENCE SECRETARIAT AND INFORMATION secretariat@oncologyconferences.com.ar Web: 5
SESSION 1: IMMUNE CHECKPOINTS: MECHANISMS AND THERAPEUTIC OPPORTUNITIES Grand Ballroom I/II
THURSDAY, SEPTEMBER 27 1200-1800 REGISTRATION Ballroom Foyer 1330-1430 WELCOME AND OPENING KEYNOTE LECTURE 1330-1340 Welcome from Scientific Committee Cochairs Carlos L. Arteaga, UT Southwestern Simmons
More informationONCOLOGY PATHOLOGY. 2Annual International Congress on. Saturday, June 23. To register visit. Updated Agenda and Faculty inside
Where Pathology and Oncology Converge! Earn a maximum of 8.75 AMA PRA Category 1 Credits. 2Annual International Congress on ONCOLOGY PATHOLOGY nd Towards Harmonization of Pathology and Oncology Standards
More informationPROGRAM. Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada
Thursday, May 4 Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada Molecular Tumor Board - Case Presentation Lillian L. Siu, Patricio
More informationWhere Debate & Discussion Translate to Breakthroughs. Now Offering 2 Locations. Greatdebatesinhema.com
Part of the Oncology Learning Network Now Offering 2 Locations March 22 23, 2019 Marina del Rey Marriott Marina del Rey, California April 5 6, 2019 Crowne Plaza Times Square Manhattan, New York Where Debate
More informationAmphithéâtre Bordeaux. Amphithéâtre. C. Massard, Villejuif, CEDEX/FR. N. Rizvi, New York, NY/US
25.02.2019 08:45-09:30 Opening and welcome + Honorary award Keynote lecture 08:45-08:55 Welcome address 08:55-09:00 Presentation of the TAT 2019 Honorary Award 09:00-09:30 TAT 2018 Honorary Award Keynote
More informationICREA-FIJC ACROSS TUMOR HETEROGENEITY AND EVOLUTION IN CANCER: FROM IN SILICO STUDIES TO CLINICAL IMPACT
B A R C E L O N A, 6 T H - 7 T H M A R C H 2 0 1 7 ICREA-FIJC CONFERENCE ACROSS TUMOR HETEROGENEITY AND EVOLUTION IN CANCER: FROM IN SILICO STUDIES TO CLINICAL IMPACT AUDITORIUM, SCHOOL OF MEDICINE, UNIVERSITY
More informationCANCER DRUG DEVELOPMENT
FACILITATING SUCCESSFUL CANCER DRUG DEVELOPMENT TURNING TRIALS INTO THERAPY TRIAL ACCELERATION SERVICES: Physician-Focused Patient Recruitment TRANSLATING INNOVATION INTO PATIENT CARE CLINICAL APPLICATION
More informationKeynote Speaker. Dr. Patrick Hwu, MD Head, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center
Keynote Speaker Dr. Patrick Hwu, MD Head, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center Keynote Speaker Patrick Hwu, MD Head, Division of Cancer Medicine, The University of
More informationGastric Cancer Co-Chairs Speakers LEARNING OBJECTIVES
ESMO Preceptorship Programme Gastric Cancer Multidisciplinary management, standards of care, therapeutic targets and future perspectives 10-11 June 2016, Prague, Czech Republic Co-Chairs Andres Cervantes
More informationDiversity Clinical Research Workshop Invited Faculty
Diversity Clinical Research Workshop Invited Faculty Alex A. Adjei, MD, PhD, FACP Professor and Chair, Department of Medicine Senior Vice President of Clinical Research The Katherine Anne Gioia Chair in
More informationIndependent Medical Education Grants Published October 2018
Academy for Continued Healthcare Learning Faculty Rounds: Exploring the Advances in the Management of Invasive Fungal Infections $99,580.00 American Association for Cancer Research AACR Cancer Health Disparities
More informationINTERNATIONAL MYELOMA SOCIETY EDUCATIONAL WORKSHOP. October 27-28, 2017 Gaylord National Hotel Washington, D.C. Metro Area
INTERNATIONAL MYELOMA SOCIETY EDUCATIONAL WORKSHOP October 27-28, 2017 Gaylord National Hotel Washington, D.C. Metro Area The International Myeloma Society (IMS) is a professional, scientific and medical
More information2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives
2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives Acute Leukemia/Tumor Lysis Syndrome John M. Valgus, Pharm.D., BCOP Hematology/Oncology Specialist University of North
More informationReview Course for CLINICAL ONCOLOGISTS. A symposium to present highlights of the 2015 ASCO meeting FRIDAY, JUNE 19, 2015
Review Course for CLINICAL ONCOLOGISTS A symposium to present highlights of the 2015 ASCO meeting FRIDAY, JUNE 19, 2015 This presentation is not endorsed by or affiliated with ASCO A continuing education
More informationMultidisciplinary Genitourinary Oncology Course:
Taussig Cancer Institute and Glickman Urological Institute present Multidisciplinary Genitourinary Oncology Course: Focus on Kidney, Bladder, and Testicular Cancer Thursday, December 14, 2017 Cleveland,
More informationNEPHROTIC SYNDROME SYMPOSIUM
NEPHROTIC SYNDROME SYMPOSIUM NOVEMBER 4, 2016 8:30 AM - 3:40 PM The New York Academy of Medicine 1216 Fifth Avenue New York, NY 10029 COURSE DIRECTORS Gerald B. Appel, MD Columbia University College of
More informationCall for Nominations. Opens: May 1, 2017 Deadline: September 30, 2017
2018 Call for Nominations Opens: May 1, 2017 Deadline: September 30, 2017 About the Szent-Györgyi Prize for Progress in Cancer Research The Szent-Györgyi Prize for Progress in Cancer Research was established
More informationCharles L. Spurr Piedmont Oncology Symposium
Charles L. Spurr Piedmont Oncology Symposium Sept. 30 Oct. 1, 2016 Marina Inn at Grande Dunes Myrtle Beach, S.C. Target Audience This activity has been planned for medical, surgical, gynecologic and radiation
More informationHEMATOLOGY AND ONCOLOGY
x THE POWER OF HEMATOLOGY AND ONCOLOGY Experts. Experience. Execution. A Deeper Dive into Hematology and Oncology Medpace supports our sponsors who are advancing new anti-cancer therapies by providing
More information2008 Oncology Pharmacy Preparatory Review Course Learning Objectives
2008 Oncology Pharmacy Preparatory Review Course Learning Objectives Session 1 Symptom Management, Part I, II & III Teresa A. Mays, Pharm D., BCOP Director, Investigational Drug Department San Antonio,
More information4 th International Conference on Advances in Hematology and Oncology
4 th International Conference on Advances in Hematology and Oncology The Coeur d Alene Resort, Coeur d Alene, Idaho August 13-14, 2016 http://oncology.binayfoundation.org BINAYTARA FOUNDATION Why Attend?
More informationESMO Clinical Practice Guidelines. ECCO GUIDELINES FORUM Brussels, November 27
ESMO Clinical Practice Guidelines ECCO GUIDELINES FORUM Brussels, November 27 ESMO Clinical Practice Guidelines ESMO Consensus Conferences ESMO Pocket & Mobile Guidelines ESMO Guides for Patients History
More informationCO-CHAIRS: Andrés Cervantes, Spain Jean-Yves Douillard, France
ESMO Preceptorship Programme Colorectal Cancer Multidisciplinary management, standards of care and future perspectives Prague, Czech Republic 6-7 July 2016 CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves
More informationJason Luke, MD, FACP Assistant Professor of Medicine University of Chicago, USA BRIEF INTRODUCTION
SPEAKERS BIOGRAPHY Jason Luke, MD, FACP Assistant Professor of Medicine University of Chicago, USA Jason Luke, MD, is an Assistant Professor of Medicine at University of Chicago where he specializes in
More informationCancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development MicroTek Training Center Washington, DC October 17 19, 2018
Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development MicroTek Training Center Washington, DC October 17 19, 2018 Wednesday, October 17, 2018 8:00 8:30 AM Registration and Continental
More information17th Annual Aultman Regional CANCER SYMPOSIUM
17th Annual Aultman Regional CANCER SYMPOSIUM CONFERENCE CHAIR: David Litvak, M.D., MBA, FACS, Medical Director of Cancer Services 9 16 17 A SYMPOSIUM FOCUSING ON: A symposium focusing on current topics
More informationOncology Update. Montage July 31 Beverly Hills, California. JW Marriott San Francisco Union Square June 26 San Francisco, California
Scripps Clinic Together, clinical experts in lymphoma, lung, colorectal, breast and genitourinary cancers will discuss new clinical developments and significant therapeutic advances in these cancer types
More informationMadrid March Manuel Hidalgo. Alberto Bardelli. Lillian Siu. Josep Tabernero. Application deadline February 23 rd
Spanish National Cancer Research Centre CNIO Frontiers Meetings 2015 Madrid 22 25 March 2015 New Trends in Anticancer Drug Development Application deadline February 23 rd Organisers Manuel Hidalgo Alberto
More informationSupplemental Table 1.1: Prostate cancer prognostic tools
Supplemental Table 1.1: Prostate cancer prognostic tools Features ANN^ BioChemical Capra^ CSQS EBRT Han Outcomes Cancer Specific - - +* + - - Non-Cancer Specific - - - + - - DFS/PFS +* +* +* - +* +* Clinical
More informationCancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC October 19-21, 2016
Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC 20037 October 19-21, 2016 Wednesday, October 19, 2016 7:30 8:30 AM Registration
More informationRoche Investor Relations ASCO Planner 2017
Roche Investor Relations ASCO Planner 2017 Saturday, June 3 Session Title: Lung Cancer Non-Small Cell Metastatic Date: Sat, June 3 Time: 8:00 AM 11:30 AM Speaker Name: Ibiayi Dagogo-Jack, MD; Yuichi Takiguchi,
More informationProgress in CD: An Update On The Advances In Crohn s Disease
Dear Registrant: Wednesday, October 6, 2010 1:00 PM 2:15 PM EASTERN 12:00 PM 1:15 PM CENTRAL 11:00 AM 12:15 PM MOUNTAIN 10:00 AM 11:15 AM PACIFIC Thank you for registering for the upcoming FREE, live educational
More informationMontefiore Einstein Center for Cancer Care. Pioneering Treatments. Extraordinary Possibilities.
Montefiore Einstein Center for Cancer Care Pioneering Treatments. Extraordinary Possibilities. Dear Colleague, Now is a time of extraordinary possibility in the field of cancer research and treatment.
More informationSummary... 2 TRANSLATIONAL RESEARCH Tumour gene expression used to direct clinical decision-making for patients with advanced cancers...
ESMO 2016 Congress 7-11 October, 2016 Copenhagen, Denmark Table of Contents Summary... 2 TRANSLATIONAL RESEARCH... 3 Tumour gene expression used to direct clinical decision-making for patients with advanced
More informationInflammation and Lung Cancer
Inflammation and Lung Cancer Steven M. Dubinett Editor Inflammation and Lung Cancer 1 3 Editor Steven M. Dubinett David Geffen School of Medicine at UCLA Los Angeles California USA ISBN 978-1-4939-2723-4
More informationClinical Breakthroughs & Challenges In Hematologic Malignancies
Clinical Breakthroughs & Challenges In Hematologic Malignancies Saturday, January 19, 2013 Disney s Grand Floridian Resort Lake Buena Vista, Florida COURSE DIRECTOR CONFERENCE CONTACT Melissa.Pearson@Moffitt.org
More informationAgenda for the Metastatic Breast Cancer (MBC) Engagement Conference at Moffitt Cancer Center. June 22-23, 2018
Agenda for the Metastatic Breast Cancer (MBC) Engagement Conference at Moffitt Cancer Center June 22-23, 2018 Note: ** Indicates the activity has been approved for AMA PRA Category 1 Credit jointly provided
More informationFirst AUBMC Theranostics Conference: See What You Treat
The Division of Nuclear Medicine, PET/CT and Cyclotron Facilities, Department of Diagnostic Radiology, AUBMC presents the First AUBMC Theranostics Conference: See What You Treat Endorsed by the International
More information8:30-9:00 Increased dependence on glutamine in PTEN-deficient breast cancer Ramon E. Parsons, Icahn School of Medicine at Mount Sinai, New York, NY
CONFERENCE PROGRAM SATURDAY, OCTOBER 7 3:00 p.m.-7:00 p.m. Salon 3 of the Terrace Welcome and Keynote Lectures 6:00 p.m.-7:30 p.m. Session Chair: Ramon E. Parsons, Icahn School of Medicine at Mount Sinai,
More informationSaturday, June 6, 2015 NRB Auditorium UCLA Campus Los Angeles, California
UCLA Osteoporosis Symposium Saturday, June 6, 2015 NRB Auditorium UCLA Campus Los Angeles, California Course Description Osteoporosis is a common public health concern. More than 10 million Americans have
More informationICGC launches new project and releases more genomic data on cancer
ICGC launches new project and releases more genomic data on cancer Toronto March 15, 2012. The International Cancer Genome Consortium (ICGC) today announced a new project from South Korea to identify the
More informationRECTAL MRI WORKSHOP. One Workstation Per Participant - Space is limited! Includes Complimentary Registration to the Colorectal Centennial Symposium
RECTAL MRI WORKSHOP THURSDAY, NOVEMBER 9, 2017 Zuckerman Research Center, New York City One Workstation Per Participant - Space is limited! Includes Complimentary Registration to the Colorectal Centennial
More informationClinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer
Clinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer Questions Answered by Andrea Apolo, MD is a Lasker Clinical Research Scholar and tenure-track
More information16 th Annual Indy Hematology Review
16 th Annual Indy Hematology Review Saturday, March 9, 2019 JW Marriott Indianapolis 10 S. West Street Indianapolis, IN Presented by: Organized by: Indy Hematology Education, Inc. This Symposium is approved
More informationNovel MOAs and targets for cancer drug development What s hot off the presses?
Novel MOAs and targets for cancer drug development What s hot off the presses? Moderator: Jeremy Goldberg, President, JPG Healthcare LLC Panelists: Robert J Schneider, PhD, Associate Director, NYU Cancer
More information6:45 p.m.-7:30 p.m. Differential regulation of inflammation in the brain and spinal cord Joan M. Goverman, University of Washington, Seattle, WA
Monday, February 12, 2018 6:30 p.m.-8:15 p.m. WELCOME AND KEYNOTE LECTURES 6:30 p.m.-6:45 p.m. Welcome Conference Cochairs 6:45 p.m.-7:30 p.m. Differential regulation of inflammation in the brain and spinal
More informationAgenda for the Metastatic Breast Cancer (MBC) Engagement Conference at Moffitt Cancer Center. June 22-23, 2018
Agenda for the Metastatic Breast Cancer (MBC) Engagement Conference at Moffitt Cancer Center June 22-23, 2018 Note: ** Indicates the activity has been approved for AMA PRA Category 1 Credit jointly provided
More informationThe Current Status of Immune Checkpoint Inhibitors: Arvin Yang, MD PhD Oncology Global Clinical Research Bristol-Myers Squibb
The Current Status of Immune Checkpoint Inhibitors: A Global Overview of the Field Arvin Yang, MD PhD Oncology Global Clinical Research Bristol-Myers Squibb Immune Checkpoint Inhibitors Conference, March
More informationDisclosures. Speakers Bureau. Clinical Trial Research Funding
Interim Results of an Ongoing Phase 1, Dose Escalation Study of MGA271 (Enoblituzumab), an Fc optimized Humanized Anti B7 H3 Monoclonal Antibody, in Patients with Advanced Solid Cancer Powderly J a, Cote
More informationGenitourinary Oncology Fellowship for Physicians in China A Multidisciplinary Clinical and Research Training Opportunity at Massachusetts General
Genitourinary Oncology Fellowship for Physicians in China A Multidisciplinary Clinical and Research Training Opportunity at Massachusetts General Hospital Cancer Center 2 Genitourinary Oncology Fellowship
More informationMETASTATIC BREAST CANCER
Click Here to View at: www.iqanda-mbc.com The iq&a interactive Medical Intelligence Zone for METASTATIC BREAST CANCER Focus on Evidence-Based Treatment for Survival Prolongation Based on Receptor Status,
More informationSHORT C. V. Meletios A. Dimopoulos, MD
SHORT C. V. Meletios A. Dimopoulos, MD Meletios A. Dimopoulos, MD is Professor and Chairman of the Department of Clinical at the National and Kapodistrian, Athens, Greece. He has been elected Vice Dean
More informationALBERTA PRINCIPAL INVESTIGATORS
ALBERTA PRINCIPAL INVESTIGATORS Dr. Gregory Cairncross is Head of the Department of Clinical Neurosciences at the University of Calgary and holder of the Alberta Cancer Foundation Chair in Brain Tumor
More informationHODGKIN S AND NON-HODGKIN S LYMPHOMA
HODGKIN S AND NON-HODGKIN S LYMPHOMA edited by JOHN P. LEONARD, MD Center for Lymphoma and Myeloma Weill Medical College of Cornell University New York Presbyterian Hospital New York, NY MORTON COLEMAN,
More informationCLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016
CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016 MORNING PLENARY LECTURES: LIBERTY BALLROOM (M4) 9:00 9:15 AM Welcome and Introductions Conference Co-Chairs: Laura W. Cheever, MD, ScM; Michael S.
More informationAre the ESMO guidelines adapted to the elderly? D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim Antwerp Belgium
Are the ESMO guidelines adapted to the elderly? D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim Antwerp Belgium Clinical practice guidelines Definition > Systemically developed statements
More informationBlood & Marrow Transplant Leukemia Immunotherapy
Blood & Marrow Transplant Leukemia Immunotherapy Our Physicians Our specially trained physicians provide leadership for the Northside Hospital Blood and Marrow Transplant, Leukemia and Immunotherapy Programs,
More informationSATURDAY, NOVEMBER 4, :00 AM 4:30 PM
Virginia Oncology Associates 18 th Annual Conference NEW DEVELOPMENTS IN ONCOLOGY Addressing Novel Therapies In Oncology & Hematology SATURDAY, NOVEMBER 4, 2017 7:00 AM 4:30 PM Hilton Virginia Beach Oceanfront
More informationUpdates in Cancer Immunotherapy and Toxicity Management Seminar
Creating Path to Cancer Free Communities, Step By Step Updates in Cancer Immunotherapy and Toxicity Management Seminar March 23-24, 2018 Double Tree Hotel by Hilton 8181 Airport Blvd. Houston, TX 77061
More informationDiaTech Oncology, LLC Developer of CorrectChemo Assay
Emerging Value of the CorrectChemo Apoptosis Assay in Oncology Care Cary A. Presant, M.D., F.A.C.P. Chief Medical Officer, DiaTech Oncology Staff Physician, City of Hope Professor of Clinical Medicine,
More informationSummary... 2 GENITOURINARY TUMOURS - PROSTATE... 3
ESMO 2016 Congress 7-11 October, 2016 Copenhagen, Denmark Table of Contents Summary... 2 GENITOURINARY TUMOURS - PROSTATE... 3 Custirsen provides no additional survival benefit to cabazitaxel/prednisone
More informationHighlights from AACR 2015: The Emerging Potential of Immunotherapeutic Approaches in Non-Small Cell Lung Cancer
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationAGENDA: FEBRUARY 22, 2018 INTRODUCTION
FDA-AACR-ASTRO Clinical Development of Drug-Radiotherapy Combinations Workshop with support from Cancer Research UK Combinations Alliance February 22-23, 2018 Bethesda, MD Purpose: There is great interest
More informationPanel One: Alternative Trial Designs Based on Tumor Genetics/Pathway Characteristics
Panel One: Alternative Trial Designs Based on Tumor Genetics/Pathway Characteristics Alternative Trial Designs Based on Tumor Genetics and/or Pathway Characteristics Instead of Histology George D. Demetri,
More informationCAR T Cell Therapies Workshop
CAR T Cell Therapies Workshop May 15, 2018 Hilton Chicago Continental B Chicago Table of Contents CAR T Cell Therapies Workshop Supporters... p 2 Committee Listing... p 3 Faculty Listing... p 3 Faculty
More informationInternational Conference on Advances in Hematology and Oncology
International Conference on Advances in Hematology and Oncology The Coeur d Alene Resort, Coeur d Alene, Idaho. August 28-29, 2015 http://oncology.binayfoundation.org BINAYTARA FOUNDATION Chair s Message
More informationBone Sarcoma (MD Anderson Cancer Care Series)
Bone Sarcoma (MD Anderson Cancer Care Series) If you are searching for the book Bone Sarcoma (MD Anderson Cancer Care Series) in pdf format, in that case you come on to correct website. We furnish utter
More informationJANUARY 22, :00 AM 4:30 PM
FRIDAY, JANUARY 22, 2016 8:00 AM 4:30 PM Hilton Hotel 4200 City Avenue Philadelphia, PA 19131 Penn Medicine s Abramson Cancer Center and the Leukemia & Lymphoma Society PRESENT UPDATE IN HEMATOLOGIC CANCERS
More informationICLIO National Conference
ICLIO National Conference Immuno-oncology In The Clinic Today Lee Schwartzberg, MD, FACP Executive Director, West Cancer Center Chief, Division of Hematology/Oncology University of Tennessee Health Science
More informationCLINICAL APPLICATION OF CAR T CELLS
Memorial Sloan Kettering Cancer Center is pleased to announce CLINICAL APPLICATION OF CAR T CELLS MARCH 10-11, 2016 Conference Location: Memorial Sloan Kettering Cancer Center Zuckerman Research Center
More informationCLICK TO GO BACK TO KIOSK MENU
Clinical outcomes in patients with baseline renal dysfunction in the NETTER- Study: 77 Lu-DOTATATE vs. high dose octreotide in progressive midgut neuroendocrine tumors J. Strosberg, E. Wolin 2, B. Chasen
More informationWith Proceedings from International Medical Meetings
Penn Medicine s Abramson Cancer Center and the Leukemia & Lymphoma Society PRESENT UPDATE IN HEMATOLOGIC CANCERS With Proceedings from International Medical Meetings REGISTER ONLINE AT PENNCANCER.ORG/CME/BLOOD
More informationDraft. MD Anderson Cancer Network 2013 Education Videoconference Schedule. Topic Date Faculty Case Information Due. Holiday New Year's Day 1/1/2013
Draft MD Anderson Cancer Network 2013 Holiday New Year's Day 1/1/2013 MPC Breast 1/8/2013 Gildy Babiera, MD 1/3/2013 Associate Professor, Surgical Oncology Jennifer Litton, MD Assistant Professor, Medical
More informationMEDICAL ONCOLOGY ESO-ESMO EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN. 27 June - 2 July 2014 Brdo, Slovenia. Chairs: T. Cufer, SI R.
Flyer MMO_(4 Mar)_screen 04.04.2014 09:33 Pagina 3 MASTERCLASS ESO-ESMO EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN MEDICAL ONCOLOGY 27 June - 2 July 2014 Brdo, Slovenia Chairs: R. Herrmann, CH This
More information6:00 p.m.-7:00 p.m. Opening Keynote Address Salons EF
THURSDAY, OCTOBER 20 6:00 p.m.-7:00 p.m. Opening Keynote Address 6:00 p.m.-7:00 p.m. Title to be announced Tyler Jacks, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 7:00
More informationCancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC October 25-27, 2017
Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC 20037 October 25-27, 2017 Wednesday, October 25, 2017 7:30 8:30 AM Registration
More informationNOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May Status (G / A / R) Status (G / A / R)
Item 18-13c NOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May 2013 BREAST CANCER MCN: Breast Disease: Breast Document ready to circulate lead to be discussed
More informationPromising Bifunctional Agents in Immuno- Oncology: A Roundtable Discussion with the Experts
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationRole of PET-CT in Cancer Management
Dartmouth Radiology Third Annual Symposium: Role of PET-CT in Cancer Management March 5-7, 2010 The Mount Washington Resort Bretton Woods, New Hampshire Register online at http://ccehs1.dartmouth-hitchcock.org/eventinfo_3173
More information2018 UPDATE IN HEMATOLOGIC MALIGNANCIES with Proceedings from International Medical Meetings
FRIDAY, JANUARY 26, 2018 7:30 AM 4:30 PM Hilton Philadelphia City Avenue 4200 City Avenue Philadelphia, PA 19131 Penn Medicine s Abramson Cancer Center and the Leukemia & Lymphoma Society PRESENT 2018
More informationHouston January 27, 2018
Houston January 27, 2018 Brian Brewer Cancer Research Institute WELCOME Our Host A special thank you for hosting the Immunotherapy Patient Summit Our Sponsors This event is made possible with generous
More informationPACGENE. A Research Project funded by the National Cancer Institute. Not for Patient Use (R01 CA 97075)
Not for Patient Use PACGENE A Research Project funded by the National Cancer Institute (R01 CA 97075) Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE Consortium) Tackling an important problem.
More informationFACULTY MEMBERSHIP APPLICATION Tulane Cancer Center
FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,
More informationApril 26 th April 29 th, 2017 Kibbutz Hagoshrim, Israel WEDNESDAY, APRIL 26, rd International Congress on Molecular Targeting Therapy
3 rd International Congress on Molecular Targeting Therapy April 26 th April 29 th, 2017 Kibbutz Hagoshrim, Israel WEDNESDAY, APRIL 26, 2017 Update: Mar. 12 14:00-21:00 Registration & Check-In 16:00-17:00
More informationNATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016
33rd Annual Meeting NATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016 Thursday-Friday, June 16-17, 2016 Conference Location: MEMORIAL SLOAN KETTERING CANCER CENTER Rockefeller Research
More informationINNOVATIONS IN BRAIN TUMOR MANAGEMENT
APRIL 5-6, 2019 NEW YORK Memorial Sloan Kettering Cancer Center presents INNOVATIONS IN BRAIN TUMOR MANAGEMENT Rockefeller Research Laboratories 430 East 67th Street New York, New York INNOVATIONS IN BRAIN
More informationCancer Science nd International Conference on Oncology & Cancer Science. August 06-08, 2018 Berlin, Germany. Hosting Organization
Cancer Science 2018 2nd International Conference on Oncology & Cancer Science August 06-08, 2018 Berlin, Germany Hosting Organization Invitation Cenetri Publishing Group takes keen delectation and highly
More information2013 Oncology Pharmacy Specialty Recertification Home Study Syllabus Learning Objectives
2013 Oncology Pharmacy Specialty Recertification Home Study Syllabus Learning Objectives Breast Cancer Chad Barnett, Pharm.D., BCOP Clinical Pharmacy Specialist The University of Texas M.D. Anderson Cancer
More informationClone 3 Human Monoclonal Antibody Neutralizing Effect on HIV 2017
Science Improving Health Clone 3 Human Monoclonal Antibody Neutralizing Effect on HIV 2017 www.bioclonetics.com Invest at: www.wefunder.com/bioclonetics. Our video: https://youtu.be/spciismitxe Invest
More information15 th Annual Indy Hematology Review
15 th Annual Indy Hematology Review Saturday, March 10, 2018 JW Marriott Indianapolis 10 S. West Street Indianapolis, IN Presented by: Organized by: Indy Hematology Education, Inc. This Symposium is approved
More informationESMO-ESO Course on Medical Oncology for Medical Students Educational Programme July 2016, Valencia, Spain
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme 14-19 July 2016, Valencia, Spain Co-chairs: Andrés Cervantes, ES - Nicholas Pavlidis, GR - Susana Banerjee, UK Thursday, 14
More informationAdvances in Oncology th Annual. October 10-11, 2014 Hyatt Regency Sacramento, CA CONFERENCE DIRECTORS
15 th Annual Advances in Oncology 2014 October 10-11, 2014 Hyatt Regency Sacramento, CA (The October 10th conference is held at the Cancer Center Auditorium ) CONFERENCE DIRECTORS Helen K. Chew, M.D. Department
More informationSpeaker bios Chordoma Community Conference at MD Anderson Cancer Center
Speaker bios Chordoma Community Conference at MD Anderson Cancer Center Fredrick Castellano, MBA Fred Castellano is the Director of Managed Care Contracting for The University of Texas MD Anderson Cancer
More informationBest of Radiation Oncology
Best of Radiation Oncology A CME conference designated for 6.25 AMA PRA category I credits Friday, December 1, 2017 7:30 am 3:45 pm Time Warner Center 60 Columbus Circle 10th Floor, North Tower New York,
More informationConnections. Academic and Community Cancer Research United (ACCRU) continues to expand our portfolio of cancer treatment
Connections Vol. 7 No. 1 Spring 2017 Inside this issue Meeting news...2 Spring ACCRU Scientific Program Overview ACCRU to exhibit at ASCO 2017 Membership news...2 Top accruing members ACCRU welcomes new
More informationFighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program
Fighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program Joxel Garcia, MD, MBA Executive Director, Cancer Prevention and Control Platform Member, Moon Shots Program Leadership Team The
More informationONCOLOGY AND MALIGNANT HEMATOLOGY REVIEW CONFERENCE
ASCO 2018 ONCOLOGY AND MALIGNANT HEMATOLOGY REVIEW CONFERENCE September 28, 2018 Eastern Area Health Education Center 2600 W. Arlington Blvd. Jointly provided by: East Carolina University Department of
More informationMR-Guided Radiation Therapy: The Next Frontier in Radiation Oncology
MR-Guided Radiation Therapy: The Next Frontier in Radiation Oncology Friday, May 17, 2019 UCLA Meyer & Renee Luskin Conference Center Los Angeles, CA MR-Guided Radiation Therapy: The Next Frontier in Radiation
More informationPRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019
MONDAY, JUNE 3, 2019 7:30 AM - 9:15 AM HIGHLIGHTS OF THE DAY 8:00 AM - 9:00 AM S 8:00 AM - 9:15 AM S S 8:00 AM - 11:00 AM S Highlights of the Day Session II Bringing New and Innovative Glioblastoma Treatments
More information